Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma (Q33364244)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma |
scientific article |
Statements
1 reference
Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma (English)
1 reference
Owen A O'Connor
1 reference
John Wright
1 reference
Craig Moskowitz
1 reference
Jamie Muzzy
1 reference
Barbara MacGregor-Cortelli
1 reference
Michael Stubblefield
1 reference
David Straus
1 reference
Carol Portlock
1 reference
Elizabeth Choi
1 reference
Otila Dumetrescu
1 reference
Dixie Esseltine
1 reference
Elizabeth Trehu
1 reference
Julian Adams
1 reference
David Schenkein
1 reference
21 December 2004
1 reference
1 reference
Identifiers
1 reference